This phototheranostic strategy provides an opportunity to selectively eliminate aggressive CD44 populations in primary and metastatic TNBC, and for those TNBCs that uniformly express CD44, the opportunity to eliminate the entire population of cancer cells in the tumor. The gene discussed is CD44; the disease is neoplasm.